Cited by 42Intramuscular injections and effectsDiabetes Management and ResearchAdvancements in Transdermal Drug Delivery

Injection Technique and Pen Needle Design Affect Leakage From Skin After Subcutaneous Injections

Open access
Præstmark, Kezia Ann, Stallknecht, Bente, Jensen, Morten Lind, Sparre, Thomas, Madsen, Nils Berg, Kildegaard, Jonas·2016·Journal of Diabetes Science and Technology

Abstract

Background: After a subcutaneous injection fluid might leak out of the skin, commonly referred to as leakage or backflow. The objective was to examine the influence of needle design and injection technique on leakage after injections in the subcutaneous tissue of humans and pigs. Method: Leakage data were obtained from a post hoc analysis of clinical trial data and from a pig study. Data from the clinical study were used to determine leakage as a function of injection volume, speed and region. Data from the pig study were used to determine leakage as a function of needle wall thickness, needle taper, injection angle, and wait time from end of injection to withdrawal of needle from skin. Results: Leakage volume was positively related to injection volume. Injections in the abdomen caused less leakage than thigh injections. A 32G needle caused less leakage than a 31G and a 32G tip (tapered) needle, and a “straight in” 90° needle insertion angle caused less leakage than an angled (~45°) insertion. Wait times of minimum 3 seconds caused less leakage than immediate withdrawal of the needle after injection. Needle wall thickness and injection speed did not influence leakage. Conclusions: Leakage will be minimized using a thin needle, using 90° needle insertion in the abdomen, injecting maximum 800 µL at a time, and waiting at least 3 seconds after the injection until the needle is withdrawn from the skin.

Integrity signals

Registry

Crossref · 10.1177/1932296815626723

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Significant research is being conducted with a focus on further facilitating subcutaneous injections, such as enhancements in infusion-rate-dependent tolerability, improvements in infusion pump technology, and novel drug-delivery devices.

    “Inspired by the benefits of subcutaneous dosing to patients and the overall healthcare system, significant research is being conducted with a focus on further facilitating subcutaneous injections, such as enhancements in infusion-rate-dependent tolerability, improvements in infusion pump technology, and novel drug-delivery devices [67–69].”

The citation lists haven’t been fetched yet

References 26 · Cited by 42

Authors
Præstmark, K. A., Stallknecht, B., Jensen, M. L., Sparre, T., Madsen, N. B., & Kildegaard, J.
Affiliations
  • University of Copenhagen (DK)
  • Novo Nordisk (Denmark) (DK)
Corresponding author
Præstmark, Kezia Ann
Venue
Journal of Diabetes Science and Technology
Published
2016-01-21
Volume
10
Issue
4
Pages
914-922
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2268577918
Cited by
42
References
26
Citations by year
2026: 6 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 9 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 2 · 2016: 2
FWCI
4.41
Type
journal article
Language
en
Open access
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Health Sciences › Medicine › Emergency Medicine › Intramuscular injections and effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
subcutaneous injection, backflow, needle design, injection technique, needle gauge, injection angle, injection volume, injection speed, injection site, porcine model
MeSH terms
Adult, Aged, Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Double-Blind Method, Female, Humans, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Male, Middle Aged, Needles, Skin, Swine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review